BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37351984)

  • 1. Two-team Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection Using Transanal Approach for Rectal Cancer: A Retrospective Study.
    Shiraishi T; Ogawa H; Yamaguchi A; Shioi I; Shibasaki Y; Komine C; Ozawa N; Osone K; Okada T; Sano A; Sakai M; Sohda M; Shirabe K; Saeki H
    Anticancer Res; 2023 Jul; 43(7):3311-3319. PubMed ID: 37351984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transanal lateral lymph node dissection surgery for 5 cases of mid-low rectal cancer].
    Zeng ZW; Zhang XW; Chen JJ; Huang L; Luo SL; Kang L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):781-785. PubMed ID: 31422618
    [No Abstract]   [Full Text] [Related]  

  • 3. Two-team lateral lymph node dissection assisted by the transanal approach for locally advanced lower rectal cancer: comparison with the conventional transabdominal approach.
    Narihiro S; Kitaguchi D; Ikeda K; Hasegawa H; Teramura K; Tsukada Y; Nishizawa Y; Ito M
    Surg Endosc; 2023 Jul; 37(7):5256-5264. PubMed ID: 36973567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
    Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
    Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Experience With Transanal Total Mesorectal Excision Compared With Laparoscopic Total Mesorectal Excision for Rectal Cancer: A Propensity Score-Matched Analysis.
    Alhanafy MK; Park SS; Park SC; Park B; Kim MJ; Sohn DK; Chang HJ; Oh JH
    Dis Colon Rectum; 2020 Nov; 63(11):1500-1510. PubMed ID: 33044291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Short-term efficacy of robotic-assisted total mesorectal excision with and without lateral lymph node dissection for mid-low advanced rectal cancer: a propensity score matching analysis].
    Shi FY; Zhang L; Qin Q; Jin X; Hu CH; Yu TY; Ma L; Wang GH; Wu H; Xia P; Sun XJ; She JJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Apr; 23(4):370-376. PubMed ID: 32306605
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the short-term surgical outcomes of lateral lymph node dissection for low rectal cancer using a robotic-assisted transabdominal approach alone or supported by a transanal approach.
    Tokunaga T; Kashihara H; Yoshikawa K; Nakao T; Nishi M; Takasu C; Wada Y; Yoshimoto T; Shimada M
    Surg Endosc; 2024 Apr; 38(4):2070-2077. PubMed ID: 38438675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic lateral pelvic lymph node dissection is achievable and offers advantages as a minimally invasive surgery over the open approach.
    Nagayoshi K; Ueki T; Manabe T; Moriyama T; Yanai K; Oda Y; Tanaka M
    Surg Endosc; 2016 May; 30(5):1938-47. PubMed ID: 26275538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Safety and prognosis analysis of transanal total mesorectal excision versus laparoscopic mesorectal excision for mid-low rectal cancer].
    Sun R; Cong L; Qiu HZ; Lin GL; Wu B; Niu BZ; Sun XY; Zhou JL; Xu L; Lu JY; Xiao Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun; 25(6):522-530. PubMed ID: 35754217
    [No Abstract]   [Full Text] [Related]  

  • 10. Outcomes of transanal total mesorectal excision compared to laparoscopic total mesorectal excision: A meta-analysis of randomized controlled trials.
    Emile SH; Wignakumar A; Horesh N; Garoufalia Z; Rogers P; Zhou P; Strassmann V; Wexner SD
    Surgery; 2024 Feb; 175(2):289-296. PubMed ID: 38001011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-Team Transanal Total Mesorectal Excision and En Bloc Resection of the Lateral Pelvic Lymph Nodes, Main Iliac Vessels, and Pelvic Plexus for Locally Advanced Rectal Cancer With Lateral Lymph Node Metastasis.
    Shioi I; Ogawa H; Hosoi N; Yamaguchi A; Watanabe T; Nakazawa N; Shibasaki Y; Shiraishi T; Osone K; Okada T; Sano A; Sakai M; Sohda M; Shirabe K; Saeki H
    Surg Laparosc Endosc Percutan Tech; 2024 Apr; 34(2):237-241. PubMed ID: 38421177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transanally assisted lateral pelvic lymph node dissection for rectal cancer.
    Matsuda T; Sawada R; Hasegawa H; Yamashita K; Utsumi M; Harada H; Urakawa N; Goto H; Kanaji S; Oshikiri T; Kakeji Y
    Surg Endosc; 2023 Feb; 37(2):1562-1568. PubMed ID: 36123543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond transanal total mesorectal excision: short-term outcomes of transanal total mesorectal excision in locally advanced rectal cancer requiring resection beyond total mesorectal excision.
    Larach JT; Rajkomar AKS; Smart PJ; McCormick JJ; Heriot AG; Warrier SK
    Colorectal Dis; 2021 Apr; 23(4):823-833. PubMed ID: 33217140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-port laparoscopic total mesorectal excision with transanal resection (transabdominal transanal resection) for low rectal cancer: initial experience with 22 cases.
    Choi BJ; Lee SC; Kang WK
    Int J Surg; 2013; 11(9):858-63. PubMed ID: 23962662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laparoscopic resection of rectal cancer results in higher lymph node yield and better short-term outcomes than open surgery: a large single-center comparative study.
    Boutros M; Hippalgaonkar N; Silva E; Allende D; Wexner SD; Berho M
    Dis Colon Rectum; 2013 Jun; 56(6):679-88. PubMed ID: 23652740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robotic transanal surgery for local excision of rectal neoplasia, transanal total mesorectal excision, and repair of complex fistulae: clinical experience with the first 18 cases at a single institution.
    Atallah S; Martin-Perez B; Parra-Davila E; deBeche-Adams T; Nassif G; Albert M; Larach S
    Tech Coloproctol; 2015 Jul; 19(7):401-10. PubMed ID: 25708682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary dysfunction after rectal cancer surgery: Results from a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for clinical stage II or III lower rectal cancer (Japan Clinical Oncology Group Study, JCOG0212).
    Ito M; Kobayashi A; Fujita S; Mizusawa J; Kanemitsu Y; Kinugasa Y; Komori K; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Akasu T; Moriya Y;
    Eur J Surg Oncol; 2018 Apr; 44(4):463-468. PubMed ID: 29428473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of a Transanal TME Platform to Enable a Distal TME Dissection En Bloc with Presacral Fascia and Pelvic Sidewall with Intraoperative Radiotherapy Delivery in a Locally Advanced Rectal Cancer: Advanced Application of taTME.
    Waters PS; Peacock O; Larach T; Lee JD; McCormick JJ; Chander S; Heriot AG; Warrier SK
    J Laparoendosc Adv Surg Tech A; 2020 Jan; 30(1):53-57. PubMed ID: 31721637
    [No Abstract]   [Full Text] [Related]  

  • 19. Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer.
    Hu C; Zhang Z; Zhang L; Liu R; Yan J; Sun Q; Wang G; She J
    J Vis Exp; 2022 Feb; (180):. PubMed ID: 35225257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesorectal excision with or without lateral lymph node dissection for elderly patients with mid-low rectal cancer: safety and feasibility analysis.
    Zhou S; Mei S; Feng B; Yang Y; Wang X; Wang Q; Liu Q;
    Jpn J Clin Oncol; 2023 Jan; 53(1):26-34. PubMed ID: 36354102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.